A Randomized Phase III Study of Temozolomide and Short-Course Radiation Versus Short-Course Radiation Alone In The Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients
Phase of Trial: Phase III
Latest Information Update: 16 Mar 2017
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Registrational; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 16 Mar 2017 Results published in the New England Journal of Medicine.
- 10 Aug 2016 Status changed from active, no longer recruiting to completed.